Global Business Innovation Programme
Focus on Advanced Therapies Sweden
The UK invites Swedish Advanced Therapy Medicinal Products (ATMP) organisations and businesses to participate in targeted 1:1 meetings to share knowledge, initiate new business and find collaboration partners.
Delivered by Innovate UK, the Global Business Innovation Programme consists of a 5-day tailored visit to Sweden with the opportunity to meet and collaborate with Swedish stakeholders and experts developing ATMP. It provides a unique experience for delegates to identify international partners for technology collaboration.
UK and Sweden
In 2022, the UK and Sweden signed a joint Memorandum of Understanding on health and life sciences, highlighting ATMP as a priority. This was followed by a Strategic Partnership Agreement, signed by UK and Swedish Prime Ministers in October 2023, which re-emphasised the importance of working together in science and innovation, including in this important sector. Therefore, opportunities for UK-Swedish ATMP collaboration and partnerships are significant and well supported at a strategic level.
Sweden is recognised as one of the most innovative countries in the world and a global leader in the health and life sciences sector. With ambitions to be a world leader in ATMP development by 2030, the country benefits from a thriving biotechnology network and national initiatives coordinated by ATMP Sweden.
The UK companies taking part in this programme to Sweden are leaders in innovative and sustainable biomanufacturing processes and process technologies that enable the development of ATMP and delivery systems. They are very keen to meet Swedish companies and organisations also involved in developing these solutions, with the aim of forming collaborative partnerships, potentially commercialising them together, and for possible joint funding applications.
Innovate UK in partnership with Swedish organisations and Enterprise Europe Network has arranged 1-2-1 business meetings on the following dates.
- 24th January 2024 Gothenburg
- 25th January 2024 Lund
- 29th January - 16th February 2024 online meetings
Focus Technologies
- Manufacturing of cell therapies such as stem cell, natural killer (NK) cells, Tcell, and other engineered cell therapies
- Manufacturing of gene therapies using viral, and non-viral vectors
- mRNA and viral vector-based vaccine manufacturing
- Manufacturing of regenerative medicine
- Development of personalised medicines
Why Participate
Extend your knowledge
Meet partners to discuss developments in key technologies and the latest innovations.
Create Opportunities
Share knowledge, ideas and find partners for research and development projects.
Connect and build your international network
Register your profile, raise awareness and pre select meetings to initiate new business and find partners for collaboration and cross border co-operation.
Only UK companies who have been selected to participate in the Global Business Innovation Programme are eligible to register. The sessions are open to Swedish companies and organisations with an interest in Advanced Therapies.
Who we are
Innovate UK is the UK’s national innovation agency. We support business-led innovation in all sectors, technologies and UK regions. We help businesses grow through the development and commercialisation of new products, processes, and services, supported by an outstanding innovation ecosystem that is agile, inclusive, and easy to navigate.
Supported By
